MedicineGeneticsOncologyCarcinogenesisMolecular OncologyTumor ProgressionCancer Molecular PathologyColorectal CancerImmunohistochemistryTumor AntigensTumor Suppressor Gene InactivationTumor Suppressor GenesApc InactivationBreast Cancer HistologyBreast Cancer HistopathologyBreast Cancer Molecular SubtypesColorectal Cancer PathologyGene InactivationProtein Expression BiomarkersRecombination Activating Gene Proteins
AIMS: To investigate if the adenomatous polyposis coli (APC) protein and the deleted in colorectal cancer (DCC) protein expression can be demonstrated by an immuno-histochemical method and to study the role of APC and DCC gene inactivation in the development and progression of breast cancer using colorectal cancer as a control model. METHODS AND RESULTS: The reduced or loss of protein expression of the APC and DCC genes was studied in 27 surgical specimens of primary breast cancer using an immunohistochemical method. Reduced or lost expression was identified in 11 out of 27 samples (40.7%) for the APC gene and 15 out of 27 samples (55.6%) for the DCC gene. No statistically significant difference was observed between the reduced or lost protein expression and the histological grading of breast tumour for both the APC and the DCC gene. CONCLUSIONS: Both gene proteins can be demonstrated by the immunohistochemical method. Reduced or loss of APC and DCC gene product were observed in 40.7% and 55.6% cases of primary breast cancer respectively. Further work is required to investigate the significance of the finding.
18
Association of the <i>APC</i> Gene Product with β-Catenin
Bonnee Rubinfeld, Brian Souza, Iris Albert et al. · Science · 1993 · 1.2K citations
The APC gene product in normal and tumor cells.
K Smith, Karen A. Johnson, Tracy M. Bryan et al. · Proceedings of the National Academy of Sciences · 1993 · 435 citations
The DCC Protein and Prognosis in Colorectal Cancer
David Shibata, Philip T. Lavin, Mark L. Silverman et al. · New England Journal of Medicine · 1996 · 308 citations · Full text
Life Sciences, Genetics, Oncology +13